We have responded to a World Health Organization (WHO) consultation on improving clinical trials.
The consultation aims to find new ways to improve and strengthen clinical trials carried out across the world.
In our response, we highlight the wide-ranging work we have been doing to strengthen the clinical trials ecosystem in the UK.
- our Think Ethics programme to streamline the ethics review process in a way that earns trust and is beneficial for researchers, patients, and the public
- our Shared Commitment to embed public involvement in health and social care research, which we developed jointly with National Institute for Health and Care Research and a host of organisations from across the UK
- our Make it Public campaign to promote openness and transparency in health and social care research
Clive Collett, Interim Head of Policy and Engagement at the HRA
We are extremely pleased to contribute to this important consultation, which sets out how we can improve the quality of clinical trials and the infrastructure that supports them, both nationally and internationally.
We are dedicated to strengthening the clinical trials ecosystem in the UK and we are working with our partners to ensure we have the right support in place to promote high-quality health and social care research, which improves treatment and saves lives.
The consultation is part of the WHO resolution on strengthening clinical trials, which was adopted at the 75 World Health Assembly in May 2022.
The responses to the consultation will be consolidated into a report to be submitted to WHO’s Executive Board and the 76 World Health Assembly in 2023.
The consultation closed on Friday 11 November 2022.